ARS Pharmaceuticals
SPRY
#8299
Rank
NZ$0.54 B
Marketcap
NZ$5.41
Share price
-11.90%
Change (1 day)
-59.97%
Change (1 year)

EPS for ARS Pharmaceuticals (SPRY)

EPS in 2026 (TTM): NZ-$3.82

According to ARS Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.06. In 2025 the company made an earnings per share (EPS) of NZ-$3.18 a decrease over its 2024 EPS that were of NZ$0.15.

EPS history for ARS Pharmaceuticals from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$3.8220.16%
2025NZ-$3.18-2275%
2024NZ$0.15-114.04%
2023NZ-$1.04-34.48%
2022NZ-$1.59303%
2021NZ-$0.391800.68%
2020NZ-$0.02076